上(shàng)海麥克林生(shēng)化(huà)科技有限公司是一(yī)家高端研發用試劑産品的制造商(shāng)與供應商(shāng),旨在為(wèi)全球科技事(shì)業和工業領域客戶提供系統的産品資源及配套技術服務(wù)。
麥克林成立于2013年,公司總部設在上(shàng)海浦東新(xīn)區張江高科技園區,在美國加州、北京、廣州、成都、武漢、鄭州等主要城市(shì)設立有分(fēn)公司和辦事(shì)處,可為(wèi)全球客戶提供便捷全方位的服務(wù)。
麥克林事(shì)業朝氣蓬勃,在上(shàng)海化(huà)工園區設有20000平方米的生(shēng)産研發基地和龐大的倉儲物流中心,憑着一(yī)支富有創造天賦的專業團隊,新(xīn)技術、新(xīn)産品層出不窮。 目前,麥克林産品已達30000 多種,并呈持續增長态勢。産品包括通用試劑、藥物合成試劑、手性化(huà)合物、催化(huà)劑及配體(tǐ)、分(fēn)析試劑、生(shēng)物試劑等。麥克林的柔性生(shēng)産線能(néng)夠快(kuài)速提供小批量、多品種的産品,可以滿足實驗室研發、中試乃至規模化(huà)生(shēng)産需要。
麥克林秉承“商(shāng)德唯信、利末義本”的經營理(lǐ)念,緻力于與化(huà)學、醫(yī)藥、分(fēn)析、食品、能(néng)源、材料等領域的客戶建立互信、長久的合作(zuò)關(guān)系,為(wèi)實現(xiàn)“服務(wù)于全球的科技現(xiàn)代化(huà),為(wèi)人(rén)類科技事(shì)業繁榮提供營養品及催化(huà)劑”的使命而不懈努力!
貨号 | 項目中文名稱 | 項目英文名稱 | 項目規格 | 包裝規格 | 牌價 | 銷售價格 | CAS号 | 分(fēn)子(zǐ)式 | 分(fēn)子(zǐ)量 |
---|---|---|---|---|---|---|---|---|---|
S854405-100mg | (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 100mg | 5186 | 4148.8 | NONE6562 | C31H27O6P | 526.5 |
R854406-100mg | (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 100mg | 5760 | 4608 | NONE6563 | C29H19Cl4O4P | 604.2 |
S854407-100mg | (11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 100mg | 5760 | 4608 | NONE6564 | C29H19Cl4O4P | 604.2 |
S854408-50mg | (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 4050 | 3240 | NONE6565 | C53H43O4PSi2 | 831.1 |
S854409-50mg | (11aS)-)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 3825 | 3060 | NONE6566 | C53H39O4P | 770.8 |
R854410-50mg | (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 3780 | 3024 | NONE6567 | C47H59O6P | 750.9 |
S854411-50mg | (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 3780 | 3024 | NONE6568 | C47H59O6P | 750.9 |
S854412-50mg | (11aS)-)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 3780 | 3024 | NONE6569 | C35H35O4P | 550.6 |
R854413-50mg | (11aR)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aR)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 4545 | 3636 | NONE6570 | C49H35O4P | 718.8 |
S854414-50mg | (11aS)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | (11aS)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,≥99%e.e. | 50mg | 4545 | 3636 | NONE6571 | C49H35O4P | 718.8 |